";s:4:"text";s:4322:" Transient episodes of lightheadedness, occasionally related to blood pressure changes, may also occur.Hypotension occurs infrequently, but in some patients it may be severe enough to warrant discontinuation of therapy. Amplification of the vasodilatory effects of Isordil by sildenafil can result in severe hypotension. With an overall half-life of about 5 hours, the 5-mononitrate is cleared from the serum by denitration to isosorbide, glucuronidation to the 5-mononitrate glucuronide, and denitration/hydration to sorbitol. The drug improved initial esophageal emptying by its effect on the lower esophageal sphincter and by relieving the test meal hold-up noted to occur at the junction of the upper and midesophagus.
The Isordil brand name has been discontinued in the U.S. The relative importance of preload reduction, afterload reduction, and coronary dilatation remains undefined.Dosing regimens for most chronically used drugs are designed to provide plasma concentrations that are continuously greater than a minimally effective concentration. Isosorbide dinitrate is freely soluble in organic solvents such as acetone, alcohol, and ether, but is only sparingly soluble in water.The principal pharmacological action of isosorbide dinitrate is relaxation of vascular smooth muscle and consequent dilatation of peripheral arteries and veins, especially the latter.
Only after nitrates have been absent from the body for several hours has their anti-anginal efficacy been restored.Bioavailability of ISDN after single sublingual doses is 40 to 50%.Multiple-dose studies of sublingual ISDN pharmacokinetics have not been reported; multiple-dose studies of ingested ISDN have observed progressive increases in bioavailability during chronic therapy.
Epub 2018 Jan 15.Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJPM, Pandolfino JE; International Working Group for Disorders of Gastrointestinal Motility and Function.Nat Rev Gastroenterol Hepatol. Artsen schrijven het voor bij hoge bloeddruk, angina pectoris (hartkramp), en de ziekte van Raynaud.Soms schrijven ze het voor bij hoogteziekte, als weeënremmer bij dreigende vroeggeboorte, bij hik en bij pulmonale arteriële hypertensie.
In a modified two-litter reproduction study, there was no remarkable gross pathology and no altered fertility or gestation among rats fed isosorbide dinitrate at 25 or 100 mg/kg/day.At oral doses 35 and 150 times the maximum recommended human daily dose, isosorbide dinitrate has been shown to cause a dose-related increase in embryotoxicity (increase in mummified pups) in rabbits. No dosing regimen for isosorbide dinitrate has, however, ever actually been shown to achieve this duration of effect. Isosorbide dinitrate should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.It is not known whether isosorbide dinitrate is excreted in human milk.
Subjectively, 13 patients had their dysphagia relieved by isosorbide dinitrate and 8 by nifedipine. Patients should resist the temptation to avoid headaches by altering the schedule of their treatment with isosorbide dinitrate, since loss of headache may be associated with simultaneous loss of anti-anginal efficacy. Hypotension induced by isosorbide dinitrate may be accompanied by paradoxical bradycardia and increased angina pectoris.Nitrate therapy may aggravate the angina caused by hypertrophic cardiomyopathy.As tolerance to isosorbide dinitrate develops, the effect of sublingual nitroglycerin on exercise tolerance, although still observable, is somewhat blunted.Some clinical trials in angina patients have provided nitroglycerin for about 12 continuous hours of every 24-hour day.
Unable to load your delegates due to an error
There are no adequate, well-controlled studies in pregnant women. In the large majority of these trials, active agents were no more effective than placebo after 24 hours (or less) of continuous therapy.